SlideShare a Scribd company logo
Cholera
Cholera-Introduction
MIASMA
THEORIES versus
• Are gram-negative rods that are facultativel
word cholera is a derivative of the Greek word “choler” meaning bile
•
• First discovered by Filippo Pacini in Italy in 1854, Pacini’s results
were published under the title, “Microscopic observation and
pathological deductions on cholera
Robert Koch independently discovered a bacillus, the same that Pacini
discovered 30 years back
Epidemiology
• Cholera likely has its origins in the Indian Subcontinent;
it has been prevalent in the Ganges delta since ancient
times
• The disease first spread by trade routes (land and sea)
to Russia in 1817, then to the rest of Europe, and from
Europe to North America
• Seven cholera pandemics have occurred in the past
200 years, with the seventh originating in Indonesia in
1961
6
Continued
• The first cholera pandemic occurred in the Bengal
region of India starting in 1817 through 1824.
• The disease dispersed from India to Southeast Asia,
China, Japan, the Middle East, and southern Russia.
• The second pandemic lasted from 1827 to 1835 and
affected the United States and Europe.
• It killed 150,000 Americans during the second
pandemic.
• The third pandemic erupted in 1839, persisted until
1856, extended to North Africa, and reached South
America, for the first time specifically infringing upon
Brazil.
7
Continued
• In Russia alone, between 1847 and 1851, more than one
million people perished of the disease
• Cholera hit the sub-saharan african region during the
fourth pandemic from 1863 to 1875
• The fifth pandemic raged from 1881–1896 Sixth
pandemics raged from 1899-1923
• Between 1900 and 1920, perhaps 8 million people died
of cholera in india
• These epidemics were less fatal due to a greater
understanding of the cholera bacteria
8
Where are modern-day
• HAITI
What Is the Current Situation?
An outbreak of cholera has been ongoing in epidemics of cholera?
Haiti since October 2010. According to the
Ministere de la Sante Publique et de la Population
(MSPP), as of August 4, 2013, 669,396 cases and
8,217 deaths have been reported since the cholera
epidemic began in Haiti. Among the cases
reported, 371,099 (55.4%) were hospitalized1
cholera
Cholera is an acute diarrhoel diseases caused
by V.cholerae 01
Cholera is both an epidemic and endemic
disease
The force of infection in an epidemic is
composed of 2 components namely the force
of infection through water and the force of
infection through contacts
Agent factors
Vibrio cholerae 0 Group 1/ epidemic strains
Non-0 group 1 V.cholerae/ non epidemic
strains
Within 0 group 1 two biotypes are classical
and El Tor
Classical and El Tor are further divided into 3
serological types namely Inaba,Ogawa and
Hikojima
Agent
Resistance
Killed within 30 min by heating at 56 C or
within few seconds by boiling
They are destroyed by cresol, bleaching powder
Toxin production
The vibrios multiply in the small intestine and
produce exotoxin(enterotoxin)
Reservior of infection
Human is the only reservoir of cholera infection
in the form of case or carrier
Infective material
Stools and vomit of cases and carriers
Infective dose
Cholera is dose related 1011 organisms required
to produce clinical disease
Period of communicability
7-10days
Carriers in cholera
Four types
1)Preclinical or incubatory carriers:
2)Convalescent carriers:
patients excrete vibrios for 2-3 wks who have
not received effective antibiotic treatment
3)Contact or healthy carrier-result of subclinical
infection. gall bladder is not infected and stool
culture is +ve .
4)Chronic carrier-gall bladder is infected
.antibody titre against vibrio rises
Host
Age and sex
All ages and both sexes
Gastric acidity
Destroyed in pH of 5 or lower
Population mobility
Risk increases
Economic status
Highest in lower S-E groups
Immunity
Mainly local intestinal immune system.
vaccination gives only temporary immunity
Environmental factors
Poor environmental sanitation
Contaminated water and food
Mode of transmission
Via man to man
a) Faecally contaminated water
b) Contaminated food and drinks
c) Direct contact
Incubation period
Few hrs to 5 hrs
Clinical features
Three stages
a) Stage of evacuation-rice water appearance
b) Stage of collapse-
c) Stage of recovery
The classical form of cholera appears in 5-10%
of cases and in the rest the disease tends to be
mild
Laboratory diagnosis of cholera
a) Collection of stools
b) Vomitus
c) Water
d) Food samples
e) Transportation
f) Direct examination-dark field illumination
g) Culture methods-peptone water tellurite
h) bio-chemical test
Control of cholera
1)Verification of diagnosis
It is important to identify V.ch in the stools of
the patient
2)Notification
Cholera is a notifiable disease locally,
nationally and internationally
3)Early case finding
Search for cases
4)Establishment of treatment centers
Mild cases –ort
Severe- i.v fluids
5)Rehydration therapy
6)Adjuncts to therapy
Antibiotics should be given as soon as vomiting
has stopped
Doxycycline is DOC in adults
TMP-SMX is DOC in children
Furazolidine is DOC in pregnant women
7)Epidemiological investigation
8)Sanitation measures
a)Water control
b)Excreta disposal
c)Food sanitation
d)Disinfection
9)Chemoprophylaxis
Tetracycline is DOC
10)Vaccination
a)Parenteral vaccine
b)Oral vaccine-2 types
i)Killed whole cell V.cholerae 01
ii)Live attenuated classical V.cholerae strain
11)Health education
WHO Global Task Force on
Cholera
• Launched in 1992, 44th world health
assembly
• Aim -reduce mortality and morbidity
associated with the disease and to address the
social and economic consequences of cholera
• Partnership brings together governmental and non-
governmental organizations, UN agencies, and
scientific institutions
• Develop technical guidelines and training
materials for cholera control
Current priority activities of WHOGlobal
Task Force on Cholera
• Encouraging improved surveillance , to identify high risk
areas and guide intervention
Providing evidence based support to countries for
preparedness and response
Gaining evidence on the use of oral cholera vaccines as an
additional public health tool to diminish incidence of cholera
in high risk areas and vulnerable groups
Linking health and management of the environment in order
to improve access to safe water for vulnerable populations
and diminish incidence of waterborne diseases
Prevention and control of cholera outbreaks:
WHO policy and recommendations
Main tools for cholera control
• Proper and timely case management in cholera treatment centres
• Specific training for proper case management, including avoidance
of nosocomial infections
• Sufficient pre-positioned medical supplies for case management
(e.g. Diarrhoeal disease kits)
• Improved access to water, effective sanitation, proper waste
management and vector control
• Enhanced hygiene and food safety practices Improved
communication and public information
Cholera vaccines
•WHO recommends that immunization with currently
available cholera vaccines be used in conjunction with the
usually recommended control measures in
-Areas where cholera is endemic
-Areas at risk of outbreaks
•Vaccines provide a short term effect while longer term
activities like improving water and sanitation are put in
place
Cholera vaccines
• Parenteral cholera vaccine not recommended by WHO (low
protective efficacy and adverse reaction)
•Two types of safe and effective oral cholera vaccines
currently available
➢Both are whole-cell killed vaccines
➢Both have sustained protection of over 50% lasting for two years in
endemic settings.
➢Both vaccines are WHO-prequalified and licensed over 60
countries.
➢Both vaccines are administered in two doses given between seven
days and six weeks apart
➢Recently, however, researchers have suggested that oral cholera
vaccines induce “herd immunity”1
1.Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, Rao M, Holmgren J, Clemens JD.Herd immunity conferred by killed oral cholera
vaccines in Bangladesh: areanalysis.Lancet. 2005 Jul 2-8;366(9479):44-9
Dukoral
• Vaccine with the b-subunit
• Given in 150 ml of safe water
• Short-term protection of 85–90% against V. Cholerae
O1 among all age groups at 4–6 months following
immunization
Shanchol
• Provides longer-term protection against V. Cholerae
O1 and O139 in children under five years of age
International Health Regulations
• 194 countries across the globe, including all the
Member States of WHO
• Aim- the international community prevent and
respond to acute public health risks that have the
potential to cross borders and threaten people
worldwide
• Surveillance for prevention, preparedness and early
warning
• Imposing travel and trade restrictions have proven
inefficient and risk to divert useful resources.
• WHO has no information -imported food from
affected countries has ever been implicated in
outbreaks of cholera in importing countries
WHO recommendations to unaffected
neighbouring countries
• Improve preparedness to rapidly respond to an
outbreak, should cholera spread accross
borders, and limit its consequences
• Improve surveillance to obtain better data for risk
assessment and early detection of outbreaks,
including establishing an active surveillance system
Measures should be avoided,
(ineffective, costly and
counter-productive)
• Routine treatment of a community with antibiotics,
or mass chemoprophylaxis (no effect on the spread
of cholera, can increase antimicrobial resistance and
provides a false sense of security)
• Restrictions in travel and trade between countries or
between different regions of a country (hampers
good cooperation spirit between institutions and
countries instead of uniting efforts)
Key messages
• Cholera is an acute diarrhoeal disease that can kill within hours if
left untreated
• There are 100 000–120 000 deaths due to cholera every year of
which only a small proportion are reported to WHO
• Up to 80% of cases can be successfully treated with oral
rehydration salts (ORS)
• About 75% of people infected with Vibrio cholerae O1 or O139 do
not develop any symptoms
• Typical at-risk areas of cholera include peri-urban slums with
limited access to safe drinking water and lack of proper sanitation
Key messages
• Surveillance is paramount to identify vulnerable populations living
in hotspots
• Cholera is a preventable disease provided that safe water and
proper sanitation are made available
• Cholera is a preventable disease provided that safe water and
proper sanitation are made available
• Safe and effective oral cholera vaccines are now part of the cholera
control package
• Today, no country requires proof of cholera vaccination as a
condition for entry
cholera.ppt

More Related Content

Similar to cholera.ppt

cholera
choleracholera
Typhoid fever
Typhoid feverTyphoid fever
INFECTIOUS DISEASES.pptx
INFECTIOUS DISEASES.pptxINFECTIOUS DISEASES.pptx
INFECTIOUS DISEASES.pptx
Great64
 
Emerging and re-emerging diseses part2 (INCLUDES ANTIMICROBIAL RESISTANCE)
Emerging and re-emerging diseses part2 (INCLUDES ANTIMICROBIAL RESISTANCE)Emerging and re-emerging diseses part2 (INCLUDES ANTIMICROBIAL RESISTANCE)
Emerging and re-emerging diseses part2 (INCLUDES ANTIMICROBIAL RESISTANCE)
Dr. Mamta Gehlawat
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
Ali Najat
 
Cholera
CholeraCholera
Cholera
KULDEEP VYAS
 
Influenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptxInfluenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptx
Rahul Netragaonkar
 
Epidemiology of Cholera
Epidemiology of CholeraEpidemiology of Cholera
Epidemiology of Cholera
MAHESWARI JAIKUMAR
 
Dysentery
DysenteryDysentery
Dysentery
Chanda Jabeen
 
cholera and diarrhoea
cholera and diarrhoeacholera and diarrhoea
cholera and diarrhoea
bypo hemalatha
 
Control and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptxControl and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptx
Bhoj Raj Singh
 
Poliomyelitis.pptx
Poliomyelitis.pptxPoliomyelitis.pptx
Poliomyelitis.pptx
Dr. Chirag Sonkusare
 
Epidemiology of Cholera
Epidemiology of CholeraEpidemiology of Cholera
Epidemiology of Cholera
Dr Shubhangi (Kshirsagar) Hedau
 
Communicable diseases tb
Communicable diseases  tbCommunicable diseases  tb
Communicable diseases tb
drjagannath
 
Enteric fever
Enteric feverEnteric fever
Enteric fever
Priyamadhaba Behera
 
NSG MGNT IN COMMUNICABLE DISEAES.ppt
NSG MGNT IN COMMUNICABLE DISEAES.pptNSG MGNT IN COMMUNICABLE DISEAES.ppt
NSG MGNT IN COMMUNICABLE DISEAES.ppt
minkmin91
 
Cholera Eltor
Cholera EltorCholera Eltor
Cholera Eltor
Lean
 
Epidemiology of cholera
Epidemiology of choleraEpidemiology of cholera
Epidemiology of cholera
Namita Batra
 
Dengue.pptx
Dengue.pptxDengue.pptx
Epidemiological Perspective of Typhoid Fever
Epidemiological Perspective of Typhoid FeverEpidemiological Perspective of Typhoid Fever
Epidemiological Perspective of Typhoid Fever
Jagat Upadhyay
 

Similar to cholera.ppt (20)

cholera
choleracholera
cholera
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
INFECTIOUS DISEASES.pptx
INFECTIOUS DISEASES.pptxINFECTIOUS DISEASES.pptx
INFECTIOUS DISEASES.pptx
 
Emerging and re-emerging diseses part2 (INCLUDES ANTIMICROBIAL RESISTANCE)
Emerging and re-emerging diseses part2 (INCLUDES ANTIMICROBIAL RESISTANCE)Emerging and re-emerging diseses part2 (INCLUDES ANTIMICROBIAL RESISTANCE)
Emerging and re-emerging diseses part2 (INCLUDES ANTIMICROBIAL RESISTANCE)
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Cholera
CholeraCholera
Cholera
 
Influenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptxInfluenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptx
 
Epidemiology of Cholera
Epidemiology of CholeraEpidemiology of Cholera
Epidemiology of Cholera
 
Dysentery
DysenteryDysentery
Dysentery
 
cholera and diarrhoea
cholera and diarrhoeacholera and diarrhoea
cholera and diarrhoea
 
Control and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptxControl and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptx
 
Poliomyelitis.pptx
Poliomyelitis.pptxPoliomyelitis.pptx
Poliomyelitis.pptx
 
Epidemiology of Cholera
Epidemiology of CholeraEpidemiology of Cholera
Epidemiology of Cholera
 
Communicable diseases tb
Communicable diseases  tbCommunicable diseases  tb
Communicable diseases tb
 
Enteric fever
Enteric feverEnteric fever
Enteric fever
 
NSG MGNT IN COMMUNICABLE DISEAES.ppt
NSG MGNT IN COMMUNICABLE DISEAES.pptNSG MGNT IN COMMUNICABLE DISEAES.ppt
NSG MGNT IN COMMUNICABLE DISEAES.ppt
 
Cholera Eltor
Cholera EltorCholera Eltor
Cholera Eltor
 
Epidemiology of cholera
Epidemiology of choleraEpidemiology of cholera
Epidemiology of cholera
 
Dengue.pptx
Dengue.pptxDengue.pptx
Dengue.pptx
 
Epidemiological Perspective of Typhoid Fever
Epidemiological Perspective of Typhoid FeverEpidemiological Perspective of Typhoid Fever
Epidemiological Perspective of Typhoid Fever
 

More from Rahul Netragaonkar

HISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.pptHISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.ppt
Rahul Netragaonkar
 
commu-ppt.ppt
commu-ppt.pptcommu-ppt.ppt
commu-ppt.ppt
Rahul Netragaonkar
 
CHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.pptCHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.ppt
Rahul Netragaonkar
 
Foundation Of Communication.pptx
Foundation Of Communication.pptxFoundation Of Communication.pptx
Foundation Of Communication.pptx
Rahul Netragaonkar
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
Rahul Netragaonkar
 
Diabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptxDiabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptx
Rahul Netragaonkar
 
Descriptive Studies.pptx
Descriptive Studies.pptxDescriptive Studies.pptx
Descriptive Studies.pptx
Rahul Netragaonkar
 
Case control studies.ppt
Case control studies.pptCase control studies.ppt
Case control studies.ppt
Rahul Netragaonkar
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
Rahul Netragaonkar
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
Rahul Netragaonkar
 
Cholera ppt.ppt
Cholera ppt.pptCholera ppt.ppt
Cholera ppt.ppt
Rahul Netragaonkar
 
C05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.pptC05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.ppt
Rahul Netragaonkar
 
cancer-ppt.pptx
cancer-ppt.pptxcancer-ppt.pptx
cancer-ppt.pptx
Rahul Netragaonkar
 
swine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptxswine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptx
Rahul Netragaonkar
 
Cancer.pptx
Cancer.pptxCancer.pptx
Cancer.pptx
Rahul Netragaonkar
 
Mumps & Rubella.pptx
Mumps & Rubella.pptxMumps & Rubella.pptx
Mumps & Rubella.pptx
Rahul Netragaonkar
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
Rahul Netragaonkar
 
ARI & Influenza.pptx
ARI & Influenza.pptxARI & Influenza.pptx
ARI & Influenza.pptx
Rahul Netragaonkar
 
Epidemiological study and designs.pptx
Epidemiological study and designs.pptxEpidemiological study and designs.pptx
Epidemiological study and designs.pptx
Rahul Netragaonkar
 
JE & Filariasis.pptx
JE & Filariasis.pptxJE & Filariasis.pptx
JE & Filariasis.pptx
Rahul Netragaonkar
 

More from Rahul Netragaonkar (20)

HISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.pptHISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.ppt
 
commu-ppt.ppt
commu-ppt.pptcommu-ppt.ppt
commu-ppt.ppt
 
CHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.pptCHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.ppt
 
Foundation Of Communication.pptx
Foundation Of Communication.pptxFoundation Of Communication.pptx
Foundation Of Communication.pptx
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
 
Diabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptxDiabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptx
 
Descriptive Studies.pptx
Descriptive Studies.pptxDescriptive Studies.pptx
Descriptive Studies.pptx
 
Case control studies.ppt
Case control studies.pptCase control studies.ppt
Case control studies.ppt
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
 
Cholera ppt.ppt
Cholera ppt.pptCholera ppt.ppt
Cholera ppt.ppt
 
C05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.pptC05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.ppt
 
cancer-ppt.pptx
cancer-ppt.pptxcancer-ppt.pptx
cancer-ppt.pptx
 
swine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptxswine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptx
 
Cancer.pptx
Cancer.pptxCancer.pptx
Cancer.pptx
 
Mumps & Rubella.pptx
Mumps & Rubella.pptxMumps & Rubella.pptx
Mumps & Rubella.pptx
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
ARI & Influenza.pptx
ARI & Influenza.pptxARI & Influenza.pptx
ARI & Influenza.pptx
 
Epidemiological study and designs.pptx
Epidemiological study and designs.pptxEpidemiological study and designs.pptx
Epidemiological study and designs.pptx
 
JE & Filariasis.pptx
JE & Filariasis.pptxJE & Filariasis.pptx
JE & Filariasis.pptx
 

Recently uploaded

Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 

Recently uploaded (20)

Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 

cholera.ppt

  • 3. • Are gram-negative rods that are facultativel word cholera is a derivative of the Greek word “choler” meaning bile • • First discovered by Filippo Pacini in Italy in 1854, Pacini’s results were published under the title, “Microscopic observation and pathological deductions on cholera Robert Koch independently discovered a bacillus, the same that Pacini discovered 30 years back
  • 4.
  • 5.
  • 6. Epidemiology • Cholera likely has its origins in the Indian Subcontinent; it has been prevalent in the Ganges delta since ancient times • The disease first spread by trade routes (land and sea) to Russia in 1817, then to the rest of Europe, and from Europe to North America • Seven cholera pandemics have occurred in the past 200 years, with the seventh originating in Indonesia in 1961 6
  • 7. Continued • The first cholera pandemic occurred in the Bengal region of India starting in 1817 through 1824. • The disease dispersed from India to Southeast Asia, China, Japan, the Middle East, and southern Russia. • The second pandemic lasted from 1827 to 1835 and affected the United States and Europe. • It killed 150,000 Americans during the second pandemic. • The third pandemic erupted in 1839, persisted until 1856, extended to North Africa, and reached South America, for the first time specifically infringing upon Brazil. 7
  • 8. Continued • In Russia alone, between 1847 and 1851, more than one million people perished of the disease • Cholera hit the sub-saharan african region during the fourth pandemic from 1863 to 1875 • The fifth pandemic raged from 1881–1896 Sixth pandemics raged from 1899-1923 • Between 1900 and 1920, perhaps 8 million people died of cholera in india • These epidemics were less fatal due to a greater understanding of the cholera bacteria 8
  • 9.
  • 10.
  • 11.
  • 12. Where are modern-day • HAITI What Is the Current Situation? An outbreak of cholera has been ongoing in epidemics of cholera? Haiti since October 2010. According to the Ministere de la Sante Publique et de la Population (MSPP), as of August 4, 2013, 669,396 cases and 8,217 deaths have been reported since the cholera epidemic began in Haiti. Among the cases reported, 371,099 (55.4%) were hospitalized1
  • 13. cholera Cholera is an acute diarrhoel diseases caused by V.cholerae 01 Cholera is both an epidemic and endemic disease The force of infection in an epidemic is composed of 2 components namely the force of infection through water and the force of infection through contacts
  • 14. Agent factors Vibrio cholerae 0 Group 1/ epidemic strains Non-0 group 1 V.cholerae/ non epidemic strains Within 0 group 1 two biotypes are classical and El Tor Classical and El Tor are further divided into 3 serological types namely Inaba,Ogawa and Hikojima
  • 15. Agent Resistance Killed within 30 min by heating at 56 C or within few seconds by boiling They are destroyed by cresol, bleaching powder Toxin production The vibrios multiply in the small intestine and produce exotoxin(enterotoxin)
  • 16. Reservior of infection Human is the only reservoir of cholera infection in the form of case or carrier Infective material Stools and vomit of cases and carriers Infective dose Cholera is dose related 1011 organisms required to produce clinical disease Period of communicability 7-10days
  • 17. Carriers in cholera Four types 1)Preclinical or incubatory carriers: 2)Convalescent carriers: patients excrete vibrios for 2-3 wks who have not received effective antibiotic treatment 3)Contact or healthy carrier-result of subclinical infection. gall bladder is not infected and stool culture is +ve . 4)Chronic carrier-gall bladder is infected .antibody titre against vibrio rises
  • 18. Host Age and sex All ages and both sexes Gastric acidity Destroyed in pH of 5 or lower Population mobility Risk increases Economic status Highest in lower S-E groups Immunity Mainly local intestinal immune system. vaccination gives only temporary immunity
  • 19. Environmental factors Poor environmental sanitation Contaminated water and food Mode of transmission Via man to man a) Faecally contaminated water b) Contaminated food and drinks c) Direct contact Incubation period Few hrs to 5 hrs
  • 20. Clinical features Three stages a) Stage of evacuation-rice water appearance b) Stage of collapse- c) Stage of recovery The classical form of cholera appears in 5-10% of cases and in the rest the disease tends to be mild
  • 21. Laboratory diagnosis of cholera a) Collection of stools b) Vomitus c) Water d) Food samples e) Transportation f) Direct examination-dark field illumination g) Culture methods-peptone water tellurite h) bio-chemical test
  • 22. Control of cholera 1)Verification of diagnosis It is important to identify V.ch in the stools of the patient 2)Notification Cholera is a notifiable disease locally, nationally and internationally 3)Early case finding Search for cases
  • 23. 4)Establishment of treatment centers Mild cases –ort Severe- i.v fluids 5)Rehydration therapy 6)Adjuncts to therapy Antibiotics should be given as soon as vomiting has stopped Doxycycline is DOC in adults TMP-SMX is DOC in children Furazolidine is DOC in pregnant women
  • 24. 7)Epidemiological investigation 8)Sanitation measures a)Water control b)Excreta disposal c)Food sanitation d)Disinfection 9)Chemoprophylaxis Tetracycline is DOC
  • 25. 10)Vaccination a)Parenteral vaccine b)Oral vaccine-2 types i)Killed whole cell V.cholerae 01 ii)Live attenuated classical V.cholerae strain 11)Health education
  • 26.
  • 27. WHO Global Task Force on Cholera • Launched in 1992, 44th world health assembly • Aim -reduce mortality and morbidity associated with the disease and to address the social and economic consequences of cholera • Partnership brings together governmental and non- governmental organizations, UN agencies, and scientific institutions • Develop technical guidelines and training materials for cholera control
  • 28. Current priority activities of WHOGlobal Task Force on Cholera • Encouraging improved surveillance , to identify high risk areas and guide intervention Providing evidence based support to countries for preparedness and response Gaining evidence on the use of oral cholera vaccines as an additional public health tool to diminish incidence of cholera in high risk areas and vulnerable groups Linking health and management of the environment in order to improve access to safe water for vulnerable populations and diminish incidence of waterborne diseases
  • 29. Prevention and control of cholera outbreaks: WHO policy and recommendations Main tools for cholera control • Proper and timely case management in cholera treatment centres • Specific training for proper case management, including avoidance of nosocomial infections • Sufficient pre-positioned medical supplies for case management (e.g. Diarrhoeal disease kits) • Improved access to water, effective sanitation, proper waste management and vector control • Enhanced hygiene and food safety practices Improved communication and public information
  • 30. Cholera vaccines •WHO recommends that immunization with currently available cholera vaccines be used in conjunction with the usually recommended control measures in -Areas where cholera is endemic -Areas at risk of outbreaks •Vaccines provide a short term effect while longer term activities like improving water and sanitation are put in place
  • 31. Cholera vaccines • Parenteral cholera vaccine not recommended by WHO (low protective efficacy and adverse reaction) •Two types of safe and effective oral cholera vaccines currently available ➢Both are whole-cell killed vaccines ➢Both have sustained protection of over 50% lasting for two years in endemic settings. ➢Both vaccines are WHO-prequalified and licensed over 60 countries. ➢Both vaccines are administered in two doses given between seven days and six weeks apart ➢Recently, however, researchers have suggested that oral cholera vaccines induce “herd immunity”1 1.Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, Rao M, Holmgren J, Clemens JD.Herd immunity conferred by killed oral cholera vaccines in Bangladesh: areanalysis.Lancet. 2005 Jul 2-8;366(9479):44-9
  • 32. Dukoral • Vaccine with the b-subunit • Given in 150 ml of safe water • Short-term protection of 85–90% against V. Cholerae O1 among all age groups at 4–6 months following immunization Shanchol • Provides longer-term protection against V. Cholerae O1 and O139 in children under five years of age
  • 33. International Health Regulations • 194 countries across the globe, including all the Member States of WHO • Aim- the international community prevent and respond to acute public health risks that have the potential to cross borders and threaten people worldwide • Surveillance for prevention, preparedness and early warning • Imposing travel and trade restrictions have proven inefficient and risk to divert useful resources. • WHO has no information -imported food from affected countries has ever been implicated in outbreaks of cholera in importing countries
  • 34. WHO recommendations to unaffected neighbouring countries • Improve preparedness to rapidly respond to an outbreak, should cholera spread accross borders, and limit its consequences • Improve surveillance to obtain better data for risk assessment and early detection of outbreaks, including establishing an active surveillance system
  • 35. Measures should be avoided, (ineffective, costly and counter-productive) • Routine treatment of a community with antibiotics, or mass chemoprophylaxis (no effect on the spread of cholera, can increase antimicrobial resistance and provides a false sense of security) • Restrictions in travel and trade between countries or between different regions of a country (hampers good cooperation spirit between institutions and countries instead of uniting efforts)
  • 36. Key messages • Cholera is an acute diarrhoeal disease that can kill within hours if left untreated • There are 100 000–120 000 deaths due to cholera every year of which only a small proportion are reported to WHO • Up to 80% of cases can be successfully treated with oral rehydration salts (ORS) • About 75% of people infected with Vibrio cholerae O1 or O139 do not develop any symptoms • Typical at-risk areas of cholera include peri-urban slums with limited access to safe drinking water and lack of proper sanitation
  • 37. Key messages • Surveillance is paramount to identify vulnerable populations living in hotspots • Cholera is a preventable disease provided that safe water and proper sanitation are made available • Cholera is a preventable disease provided that safe water and proper sanitation are made available • Safe and effective oral cholera vaccines are now part of the cholera control package • Today, no country requires proof of cholera vaccination as a condition for entry